Prener Anne
Insider CIK 1797917 · KROS Director · RUBY Director · KLDO Director · GLTO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | A Award deriv | 2026-07-01 | 2026-07-06 | 14,870 | — | $0 | 14,870 | SEC↗ |
| KROS Keros Therapeutics, Inc. | A Award | 2026-07-01 | 2026-07-06 | 13,786 | — | $0 | 13,786 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 720 | — | $0 | 720 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2022-06-14 | 2022-06-15 | 18,000 | — | $0 | 18,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2022-05-12 | 2022-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2021-06-30 | 2021-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2021-05-26 | 2021-05-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2021-05-12 | 2021-05-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2021-01-08 | 2021-01-08 | 6,000 | — | $0 | 6,000 | SEC↗ |
| GLTO Galecto, Inc. | A Award deriv | 2021-01-08 | 2021-01-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2020-06-30 | 2020-07-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | A Award deriv | 2020-04-01 | 2020-04-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | A Award deriv | 2019-12-31 | 2020-01-03 | 50,000 | — | $0 | 50,000 | SEC↗ |